This role sits at the critical junction between discovery and delivery, converting mechanism of action, biomarkers and clinical profiles into clear, value-maximizing pathways that work in the real world
Job Summary
This role sits at the critical junction between discovery and delivery, converting mechanism of action, biomarkers and clinical profiles into clear, value-maximizing pathways that work in the real world.
You will lead how our earliest oncology assets progress from Phase 2 decisions through registration and launch, shaping evidence, access and diagnostic strategies that reflect local standards of care and payer expectations.
Here your decisions directly shape how cutting-edge oncology medicines reach patients sooner, with real ownership to adapt for local standards of care and payer needs.
Matching Summary
This role sits at the critical junction between discovery and delivery, converting mechanism of action, biomarkers and clinical profiles into clear, value-maximizing pathways that work in the real world.
Skills & Requirements
Must-have
Oncology asset strategy
Phase 2 through registration and launch
International market access
Companion Diagnostics strategy
Cross-functional leadership
Nice-to-have
Entrepreneurial thinking
Data-driven decisions
Local ownership empowerment
Big data and real-world evidence
Key Requirements
Advanced scientific qualification (MD, PhD, or PharmD)
Deep Oncology expertise
Senior leadership integrating science and commercial strategy